Lymphoseek: A molecular imaging agent for melanoma sentinel lymph node mapping

Annals of Surgical Oncology

Volumn 14, Issue 2, 2007, Pages 913-921

  Wallace, Anne M ^a,b   Hoh, Carl K ^b,c   Ellner, Scott J ^a,b   Darrah, Denise D ^b   Schulteis, Gery ^d   Vera, David R ^b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California   (United States)

Author keywords

99mTc DTPA mannosyl dextran; Lymphoseek; Melanoma; Molecular imaging; Radiopharmaceutical; Sentinel lymph node biopsy

Indexed keywords

LYMPHOSEEK; RADIOPHARMACEUTICAL AGENT; TECHNETIUM DIETHYLENETRIAMINE PENTAACETIC ACID MANNOSYL DEXTRAN TC 99M; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG UPTAKE; FEMALE; HUMAN; MALE; MELANOMA; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PHASE 1 CLINICAL TRIAL; RADIATION ABSORPTION; RADIOACTIVITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; WHOLE BODY SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TECHNETIUM TC 99M PENTETATE; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 33846577300     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9099-4     Document Type: Article

References (20)

1. Steer CJ. (1996) Receptor-mediated endocytosis: mechanisms, biologic function, and molecular properties. In: Zakim D, Boyer TD eds. Hepatology. A Textbook of Liver Disease 3WB Saunders, Philadelphia, pp 149-214.
2. 99mTc]DTPA-mannosyl-dextran. J Nucl Med 2001; 42:951-9.
3. Méndez J, Wallace AM, Hoh CK, DR.Vera . Detection of gastric and colonic sentinel nodes via endoscopic administration of Lymphoseek in pigs. J Nucl Med 2003; 44:1677-81.
4. Wallace AM, Ellner SJ, Méndez J, et al. Minimally invasive sentinel lymph node mapping of the pig colon with Lympho-seek. Surgery 2003; 139:217-23.
5. Ellner SJ, Méndez J, Vera DR, Hoh CK, Ashburn WL, Wallace AM. Sentinel lymph node mapping of the colon and stomach using Lymphoseek in a pig model. Ann Surg Oncol 2004; 11:674-81.
6. Salem CE, Wallace AM, Hoh CK, Vera DR. A preclinical study of prostate sentinel node mapping with Lymphoseek. Ann Surg Oncol 2004; 175:774-8.
7. Wallace AM, Hoh CK, Vera DR, Darrah D, Schulteis G. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol 2003; 10:531-8.
8. 99mTc]DTPA-mannosyl-dextran for breast cancer sentinel node mapping. Nucl Med Biol 2003; 30:805-10.
9. Clark WH Jr, Elder DE, Guerry DT, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the pre-cursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15:1147-65.
10. 99mTc] DTPA-mannosyl-dextran. Nucl Med Biol 2003; 30:457-64.
11. Silberstein EB, Ryan J. Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine. J Nucl Med 1996; 37:185-92.
12. National Cancer Institute. Common Toxicity Criteria Manual, Version 2.0. Cancer Therapy Evaluation Program, Bethesda MD, 1999.
13. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37:538-46.
14. International Committee on Radiological Protection Recommendations of the International Commission on Radiological Protection. 1990 New York: International Committee on Radiological Protection; 1991.
15. Snyder WS, Ford MR, Warner GG, Watson SB. "S" Absorbed Dose per Unit Cumulative Activity for Selected Radionuclides and Organs (MIRD Pamphlet No. 11) New York: The Society of Nuclear Medicine; 1975 pp 92-3.
16. US Food and Drug Administration Guidance for Industry, Developing Medical Imaging Drugs and Biological Products: Part 3. Design, Analysis, and Interpretation of Clinical Studies Rockville, MD: US Department of Health and Human Services; 2004.
17. Bergqvist L, Strand S-E, Persson BRR, Hafstrom L, Jonsson PE. Dosimetry in lymphoscintigraphy of Tc-99m antimony sulfide colloid. J Nucl Med 1982; 23:698-705.
18. Nieweg OE, Olmos RAV, Kapteijn AE, Hoefnagel CA. (2000) Cutaneous lymphoscintigraphy. In: Nieweg OE, Essner R, Reintgen DS, Thompson JF eds. Lymphatic Mapping and Probe Applications in Oncology Marcel Dekker Inc, New York, pp 43-70.
19. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223:217-24.
20. Mariani G, Gipponi M, Moresco L, et al. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med 2002; 43:811-27.